AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $44 | -99.9% | 21,976 | +44.2% | 0.00% | -63.6% |
Q4 2020 | $70,000 | -25.5% | 15,244 | -21.8% | 0.01% | -26.7% |
Q4 2019 | $94,000 | -23.6% | 19,485 | +13.9% | 0.02% | -28.6% |
Q2 2019 | $123,000 | -63.5% | 17,110 | -28.1% | 0.02% | -61.8% |
Q1 2019 | $337,000 | – | 23,794 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $144,839,000 | 11.40% |
Eversept Partners, LP | 4,755,480 | $32,004,380 | 2.41% |
TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $109,116,000 | 1.27% |
EAM Global Investors LLC | 365,719 | $2,461,000 | 0.68% |
Signature Wealth Management Partners, LLC | 87,666 | $590,000 | 0.57% |
Jackson Creek Investment Advisors LLC | 221,043 | $1,488,000 | 0.52% |
Tranquilli Financial Advisor LLC | 71,414 | $481,000 | 0.39% |
Hillsdale Investment Management Inc. | 611,200 | $4,113,000 | 0.34% |
EAM Investors, LLC | 259,873 | $1,749,000 | 0.26% |
HUSSMAN STRATEGIC ADVISORS, INC. | 180,000 | $1,211,000 | 0.25% |